Labdiazina

Sulfadiazine, the active ingredient in Labdiazina, is a sulfonamide antibiotic presented as an oral formulation for oral use. It acts against susceptible bacteria to treat urinary tract infections, serve as prophylaxis for meningitis, and manage otitis media in patients for whom this class of agents is appropriate.

GNH USA supplies Labdiazina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality through stringent manufacturing and regulatory standards. The company provides reliable logistics and documentation for global distribution.

Labdiazina (sulfadiazine) is used in bacterial infections where inhibition of folic acid synthesis is therapeutic.

Urinary tract infections: reduces bacterial growth to resolve infection in the urinary system. Meningitis prophylaxis: prevents meningococcal infection in high‑risk exposures. Otitis media: treats middle‑ear bacterial infection to alleviate symptoms and prevent complications.

Sulfadiazine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or vomiting - Skin rash or mild itching - Headache - Diarrhea - Photosensitivity to sunlight - Mild fever

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Agranulocytosis or severe leukopenia - Hepatic dysfunction or jaundice - Acute renal impairment - Severe hypersensitivity reactions including anaphylaxis - Hemolytic anemia in susceptible individuals

When prescribing Labdiazina, clinicians should consider several safety measures.

Renal function: adjust use in patients with impaired renal function. Hepatic function: monitor liver enzymes during therapy. Allergy: avoid in patients with known sulfonamide hypersensitivity. Pregnancy: use only if potential benefits justify potential risks. Drug monitoring: perform complete blood count for prolonged treatment. Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Sulfadiazine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Methotrexate: can increase methotrexate toxicity. - Phenytoin: may reduce phenytoin levels, compromising seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce contraceptive efficacy. - Lithium: can increase lithium serum concentrations, risking toxicity.